Kayacan O, Karnak D, Delibalta M, Beder S, Karaca L, Tutkak H
Department of Chest Diseases and Tuberculosis, Ankara University Medical Faculty, 06100-Cebeci-Ankara, Turkey.
Respir Med. 2002 Jul;96(7):536-41. doi: 10.1053/rmed.2001.1284.
The sputum smear-negative patients have been a diagnostic challenge for health professionals. Adenosine deaminase (ADA) activity has been shown to rise in various body fluids of patients with tuberculosis (Tb). A prospective clinical trial was conducted to determine the diagnostic value of ADA activity in bronchoalveolar lavage (BAL) in sputum smear-negative subjects highly suggestive for pulmonary Tb. Nineteen (M/F: 15/4, mean age 46.8 +/- 16.5 years) sputum smear-negative patients highly suggestive for pulmonary Tb constituted Group I. Acid fast bacilli (AFB) grew on sputum and/or BAL culture of all subjects in this group. Twenty-nine patients (M/F: 19/10, mean age 55.7 +/- 8.0 years) with non-tuberculous pulmonary diseases constituted Group II. Ten of them had interstitial lung disease, nine lung cancer, five pneumonia and five COPD. Twelve subjects (M/F: 7/5, mean age 48.4 +/- 12.8 years) constituted the controls (Group III) undergoing fiberoptic bronchoscopy (FOB) for various indications and the lungs were found to be normal eventually. Albumin and ADA activity levels were measured in plasma and BAL in all the subjects. LocalADA was calculated. PlasmaADA and BALADA of Group I was significantly higher (P < 0.001) than that of the other groups. LocalADA was also the highest in Group I when compared with the others (P < 0.001) but that of Group II was also higher (P < 0.01) when compared with controls. With a cut-off value derived from the control subjects, sensitivity of BALADA was 100% and specificity 85.3%. Sputum PCR results are available in a couple of days whereas that of BALADA are available in a couple of hours and BALADA costs cheaper than PCR in our country. Therefore, we conclude that BALADA may be a useful, cheaper and faster diagnostic test in sputum smear-negative patients highly suggestive for pulmonary Tb. LocalADA need not be calculated as it is also significantly higher in Group II subjects and thus not as reliable as BALADA.
痰涂片阴性患者一直是卫生专业人员面临的诊断难题。腺苷脱氨酶(ADA)活性已被证明在结核病(Tb)患者的各种体液中会升高。进行了一项前瞻性临床试验,以确定ADA活性在支气管肺泡灌洗(BAL)中对高度疑似肺结核的痰涂片阴性受试者的诊断价值。19例(男/女:15/4,平均年龄46.8±16.5岁)高度疑似肺结核的痰涂片阴性患者组成第一组。该组所有受试者的痰液和/或BAL培养物中均培养出抗酸杆菌(AFB)。29例患有非结核性肺部疾病的患者(男/女:19/10,平均年龄55.7±8.0岁)组成第二组。其中10例患有间质性肺疾病,9例患有肺癌,5例患有肺炎,5例患有慢性阻塞性肺疾病(COPD)。12名受试者(男/女:7/5,平均年龄48.4±12.8岁)组成对照组(第三组),因各种适应症接受纤维支气管镜检查(FOB),最终发现肺部正常。测量了所有受试者血浆和BAL中的白蛋白和ADA活性水平,并计算了局部ADA。第一组的血浆ADA和BALADA显著高于其他组(P<0.001)。与其他组相比,第一组的局部ADA也最高(P<0.001),但与对照组相比,第二组的局部ADA也较高(P<0.01)。以对照组受试者得出的临界值计算,BALADA的敏感性为100%,特异性为85.3%。痰液PCR结果几天后可得,而BALADA结果几小时内即可获得,并且在我国BALADA的成本比PCR低。因此,我们得出结论,对于高度疑似肺结核的痰涂片阴性患者,BALADA可能是一种有用、成本更低且更快的诊断测试。无需计算局部ADA,因为第二组受试者的局部ADA也显著较高,因此不如BALADA可靠。